Advising Companies in Times of Shifting Legal Landscapes: FDA Case Studies

This program will focus on the significant legal changes that have taken place over the last year in the regulation of the pharmaceutical and biotechnology industry by the US Food and Drug Administration, including with respect to approval standards, product commercialization, and agency enforcement practices. The discussion will include how to effectively advise on the unknown in a highly regulated industry, while also finding areas of new opportunity.